Technical Challenges for CTC Implementation in Breast Cancer
Breast cancer is the most common neoplasm in women worldwide. Tissue biopsy, currently the gold standard to obtain tumor molecular information, is invasive and might be affected by tumor heterogeneity rendering it incapable to portray the complete dynamic picture by the absence of specific genetic c...
Main Authors: | Rocío Ramos-Medina, Sara López-Tarruella, María del Monte-Millán, Tatiana Massarrah, Miguel Martín |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/18/4619 |
Similar Items
-
Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes
by: Clotilde Costa, et al.
Published: (2020-04-01) -
Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology
by: Patrick C. Bailey, et al.
Published: (2019-06-01) -
CTC, ctDNA, and Exosome in Thyroid Cancers: A Review
by: Wenwen Wang, et al.
Published: (2023-09-01) -
Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs)
by: Pablo Hurtado, et al.
Published: (2020-10-01) -
Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility
by: József Petrik, et al.
Published: (2022-11-01)